GPC1 and breast cancer: Stable transfection of MDA-MB-231 and MDA-MB-468 breast cancer cells with a GPC1 antisense construct markedly decreased GPC1 protein levels and the mitogenic response to heparin-binding (HB)-EGF, FGF2, heregulin α, heregulin β, and HGF [16].